Prevalence of subclinical hypothyroidism in women with type 2 diabetes

Medical Science Monitor

Volumn 15, Issue 4, 2009, Pages

  Ishay, Avraham ^a   Chertok Shaham, Ilena ^a   Lavi, Idit ^b   Luboshitzky, Rafael ^a,c  

^a HAEMEK MEDICAL CENTER   (Israel)

^b CARMEL MEDICAL CENTER   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Subclinical hypothyroidism; Type 2 diabetes; Women

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; LIOTRIX; THYROID ANTIBODY; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; SCREENING; THYROID FUNCTION;

AGED; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOTHYROIDISM; ISRAEL; MIDDLE AGED; PREVALENCE;

EID: 65949097489     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Cooper DS: Clinical practice. Subclinical hypothyroidism. N Engl J Med, 2001; 345: 260-265
2. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC: The Colorado thyroid disease prevalence study. Arch Intern Med, 2000; 160: 526-534
3. Hollowell JG, Staehling NW, Flanders WD et al: Serum TSH, T4, and thyroid antibodies in the United States population (1988-1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab, 2002; 87: 489-499
4. Biondi B, Palmieri EA, Lombardi G, Fazio S: Subclinical hypothyroidism and cardiac function. Thyroid, 2002; 12: 505-510
5. Rodondi N, Aujesky D, Vittinghoff E et al: Subclinical hypothyroidism and the risk of coronary heart disease: a meta-analysis. Am J Med, 2006; 119: 541-551
6. Walsh JP, Bremner AP, Bulsara MK et al: Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med, 2005; 165: 2467-2472
7. Coban E, Yazicioglu G, Osdogan M: Platelet activation in subjects with subclinical hypothyroidism. Med Sci Monit, 2007; 13(4): CR211-14
8. Walsh JP, Bremner AP, Bulsara MK et al: Thyroid dysfunction and serum lipids: a community-based study. Clin Endo, 2005; 63: 670-675
9. Meier C, Staub JJ, Roth CB, Guglielmetti M et al: TSH-controlled L-thyroxin therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel thyroid study). J Clin Endocrinol Metab, 2001; 86: 4860-4866 (Pubitemid 33020533)
10. Davis JD, Stern RA, Flashman LA: Cognitive and neuropsychiatric aspects of subclinical hypothyroidism: Significance in the elderly. Cur Psych Rep, 2003; 5: 384-390
11. Monzani F, Carracio N, Del Guerra P et al: Neuromuscular symptoms and dysfunction in subclinical hypothyroid patients: beneficial effect of L-T4 replacement therapy. Clin Endo, 1999; 51: 237-242
12. Monzani F, Del Guerra P, Caraccioli N et al: Subclinical hypothyroidism: neurobehavioral features and beneficial effect of L-thyroxin treatment. J Mol Med, 2004; 71: 367-371
13. Huber G, Staub JJ, Meier C et al: Prospective study of the spontaneous course of subclinical hypothyroidism: pronostic value of thyrotropin, thyroid reserve and thyroid antibodies. J Clin Endocrinol Metab, 2002; 87: 3221-3226
14. Diez JJ, Iglesias P: Spontaneous subclinical hypothyroidism in patients older than 55 years: an analysis of natural course and risk factors for the development of overt thyroid failure. J Clin Endocrinol Metab, 2004; 89: 4890-4897
15. Gharib H, Tuttle MR, Baskin JH et al: Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. J Cin Endocrinol Metab, 2005; 90: 581-585 (Pubitemid 40116712)
16. Surks MI, Ortiz E, Daniels GH et al: Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. J Cin Endocrinol Metab, 2004; 291: 228-238
17. Gray RS, Borsey DQ, Seth J et al: Prevalence of subclinical thyroid failure in insulin-dependant diabetes. J Clin Endocrinol Metab, 1980; 50: 1034-1037
18. Perros P, McCrimmon RJ, Shaw G, Frier BM: Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diab Med, 1995; 12: 622-627
19. Chubb SAP, Davis WA, Inman Z, Davis TME: Prevalence and progression of subclinical hypothyroidism in women with type 2 diabetes: the Fremantle Diabetes Study. Clin Endocrinol, 2005; 62: 480-486
20. Warren RE, Perros P, Nyirenda MJ, Frier BM: Serumthyrotropin is a better predictor of future thyroid dysfunction than thyroid autoantibody status in biochemically euthyroid patients with diabetes: implications for screening. Thyroid, 2004; 14: 853-857
21. Smithson MJ: Screening for thyroid dysfunction in a community population of diabetic patients. Diab Med, 1998; 15: 148-150
22. Radaideh AR, Nusier MK, Amari FL et al: Thyroid dysfunction in patients with type 2 diabetes mellitus in Jordan. Saudi Med J, 2004; 25: 1046-1050
23. Badman MK, Chowdhury TA: Should thyroid function tests be done annually in all patients with diabetes? Diab Med, 2002; 19: 7-9 (Pubitemid 34587788)
24. Turnbridge WMG, Evered DC, Hall R et al: The spectrum of thyroid disease in a community: the Whickam survey. Clin Endocrinol, 1977; 7: 481-493
25. Biondi B, Palmieri EA, Klain M et al: Subclinical hyperthyroidism: clinical features ad treatment options. Eur J Endocrinol, 2005; 152(1): 1-9
26. Kanaya A, Harris F, Volpato S et al: Association between thyroid dysfunction and total cholesterol level in an older biracial population. Arch Intern Med, 2002; 162: 773-779
27. Parle JV, Franklyn JA, Cross KW et al: Prevalence and follow up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol, 1991; 34: 77-83
28. Akbar DH, Ahmed MM, Hijazi NA: Subclinical hypothyroidism in elderly women attending an outpatient clinic. Med Sci Monit, 2004; 10(5): CR229-32
29. Brabant G, Beck-Peccoz P, Jarzab B et al: Is there a need to redefine the upper normal limit of TSH? Eur J Endocrinol, 2006; 154: 633-637 (Pubitemid 43810847)
30. Surks MI, Goswami G, Daniels GH: The thyrotropin reference range should remain unchanged. J Clin Endocrinol Metab, 2005; 90: 5489-5496
31. Fatourechi W: Upper limit of normal serum thyroid-stimulating hormone: a moving and now an aging target? J Clin Endocrinol Metab, 2007; 92(12): 4560-4562 (Pubitemid 350223425)
32. Pirich C, Mullner M, Sinzinger H: Prevalence and relevance of thyroid dysfunction in 1922 cholesterol screening participants. J Clin Epidemiol, 2000; 6: 623-629
33. Vanderpump MJP, Turnbridge WMC, French JM et al: The incidence of thyroid disorders in the community: a twenty-year follow up of the Whickam survey. Clin Endocrinol, 1995; 43: 55-68
34. American Diabetes Association: Standards of medical care in diabetes. Diab Care, 2005; 28: S4-S36
35. Ringel MD, Mazzaferri EL: Subclinical thyroid dysfunction - can there be a consensus about the consensus? J Clin Endocrinol Metab, 2005; 90(1): 588-590 (Pubitemid 40116714)